Metformin Treatment of Pregnant Women With Polycystic Ovary Syndrome: a Pilot Study

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 31, 2000

Primary Completion Date

March 31, 2003

Study Completion Date

March 31, 2003

Conditions
Polycystic Ovary Syndrome
Interventions
DRUG

Metformin

Metformin 850 mg x 1 per day for the first week, and 850 mg x 2 per day for the rest of the study period.. Orally. From inclusion (before gestational week 8) to delivery. Verbal and written diet and lifestyle advices at inclusion to the study. In addition 1 mg tablet of folate and one daily multivitamin tablet.

DRUG

Placebo

Placebo, 2 tablets x 1 daily for the first week, and 2 tablets x 2 for the rest of the study period.Orally. From inclusion (that is before gestational week 12) to delivery. Verbal and written diet and lifestyle advices at inclusion to the study. In addition 1 mg tablet of folate and one daily multivitamin tablet.

Trial Locations (1)

Unknown

Departments of Obstetrics and Gynecology and Endocrinology, St. Olav's Hospital, Trondheim

All Listed Sponsors
collaborator

St. Olavs Hospital

OTHER

lead

Norwegian University of Science and Technology

OTHER

NCT03259919 - Metformin Treatment of Pregnant Women With Polycystic Ovary Syndrome: a Pilot Study | Biotech Hunter | Biotech Hunter